Cargando…

Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study

BACKGROUND: In Denmark, patients with psoriasis undergoing biological treatment have regular follow-ups, typically every 3 months. This may pose a challenge for patients who live far away from the hospital. Mobile health (mHealth) is a promising and reliable tool for the long-term management of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Trettin, Bettina, Danbjørg, Dorthe Boe, Andersen, Flemming, Feldman, Steven, Agerskov, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501531/
https://www.ncbi.nlm.nih.gov/pubmed/37632817
http://dx.doi.org/10.2196/26673
_version_ 1785106129442832384
author Trettin, Bettina
Danbjørg, Dorthe Boe
Andersen, Flemming
Feldman, Steven
Agerskov, Hanne
author_facet Trettin, Bettina
Danbjørg, Dorthe Boe
Andersen, Flemming
Feldman, Steven
Agerskov, Hanne
author_sort Trettin, Bettina
collection PubMed
description BACKGROUND: In Denmark, patients with psoriasis undergoing biological treatment have regular follow-ups, typically every 3 months. This may pose a challenge for patients who live far away from the hospital. Mobile health (mHealth) is a promising and reliable tool for the long-term management of patients with psoriasis undergoing biological treatment because the disease course can be properly monitored. Despite recent developments in mHealth, the full potential of teledermatology remains to be tapped by newer, more attractive forms of services focused on patients’ needs. OBJECTIVE: This study aims to design and develop an mHealth app to support the self-management of patients with psoriasis using a participatory design. METHODS: Using participatory design, we conducted 1 future workshop, 4 mock-up workshops, and 1 prototype test with patients and health care professionals to co-design a prototype. The process was iterative to ensure that all stakeholders would provide input into the design and outcome; this approach enabled continuous revision of the prototype until an acceptable solution was agreed upon. Data were analyzed according to the steps—plan, act, observe, and reflect—in the methodology of participatory design. RESULTS: Health care professionals and patients emphasized the importance of a more patient-centered approach, focusing on the communication and maintenance of relationships. Patients perceived consultations to be impersonal and repetitive and wanted the opportunity to contribute to the agenda while attending a consultation. Patients also stated they would prefer not to attend visits in person every 3 months. On the basis of these findings, we designed an mHealth app that could replace in-person visits and support patients at in-person visits. Video consultations, self-monitoring, and registration of patient-reported outcome data were embedded in the app. CONCLUSIONS: Using participatory design facilitated mutual learning and democratic processes that gave end users a significant influence over the solution. Despite the advantages of using participatory design in developing mHealth solutions, organizational conditions may still represent a barrier to the optimization of solutions.
format Online
Article
Text
id pubmed-10501531
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-105015312023-09-15 Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study Trettin, Bettina Danbjørg, Dorthe Boe Andersen, Flemming Feldman, Steven Agerskov, Hanne JMIR Dermatol Original Paper BACKGROUND: In Denmark, patients with psoriasis undergoing biological treatment have regular follow-ups, typically every 3 months. This may pose a challenge for patients who live far away from the hospital. Mobile health (mHealth) is a promising and reliable tool for the long-term management of patients with psoriasis undergoing biological treatment because the disease course can be properly monitored. Despite recent developments in mHealth, the full potential of teledermatology remains to be tapped by newer, more attractive forms of services focused on patients’ needs. OBJECTIVE: This study aims to design and develop an mHealth app to support the self-management of patients with psoriasis using a participatory design. METHODS: Using participatory design, we conducted 1 future workshop, 4 mock-up workshops, and 1 prototype test with patients and health care professionals to co-design a prototype. The process was iterative to ensure that all stakeholders would provide input into the design and outcome; this approach enabled continuous revision of the prototype until an acceptable solution was agreed upon. Data were analyzed according to the steps—plan, act, observe, and reflect—in the methodology of participatory design. RESULTS: Health care professionals and patients emphasized the importance of a more patient-centered approach, focusing on the communication and maintenance of relationships. Patients perceived consultations to be impersonal and repetitive and wanted the opportunity to contribute to the agenda while attending a consultation. Patients also stated they would prefer not to attend visits in person every 3 months. On the basis of these findings, we designed an mHealth app that could replace in-person visits and support patients at in-person visits. Video consultations, self-monitoring, and registration of patient-reported outcome data were embedded in the app. CONCLUSIONS: Using participatory design facilitated mutual learning and democratic processes that gave end users a significant influence over the solution. Despite the advantages of using participatory design in developing mHealth solutions, organizational conditions may still represent a barrier to the optimization of solutions. JMIR Publications 2021-05-10 /pmc/articles/PMC10501531/ /pubmed/37632817 http://dx.doi.org/10.2196/26673 Text en ©Bettina Trettin, Dorthe Boe Danbjørg, Flemming Andersen, Steven Feldman, Hanne Agerskov. Originally published in JMIR Dermatology (http://derma.jmir.org), 10.05.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology Research, is properly cited. The complete bibliographic information, a link to the original publication on http://derma.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Trettin, Bettina
Danbjørg, Dorthe Boe
Andersen, Flemming
Feldman, Steven
Agerskov, Hanne
Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
title Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
title_full Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
title_fullStr Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
title_full_unstemmed Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
title_short Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
title_sort development of an mhealth app for patients with psoriasis undergoing biological treatment: participatory design study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501531/
https://www.ncbi.nlm.nih.gov/pubmed/37632817
http://dx.doi.org/10.2196/26673
work_keys_str_mv AT trettinbettina developmentofanmhealthappforpatientswithpsoriasisundergoingbiologicaltreatmentparticipatorydesignstudy
AT danbjørgdortheboe developmentofanmhealthappforpatientswithpsoriasisundergoingbiologicaltreatmentparticipatorydesignstudy
AT andersenflemming developmentofanmhealthappforpatientswithpsoriasisundergoingbiologicaltreatmentparticipatorydesignstudy
AT feldmansteven developmentofanmhealthappforpatientswithpsoriasisundergoingbiologicaltreatmentparticipatorydesignstudy
AT agerskovhanne developmentofanmhealthappforpatientswithpsoriasisundergoingbiologicaltreatmentparticipatorydesignstudy